Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress
- 1 January 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 303 (3) , 1061-1066
- https://doi.org/10.1124/jpet.102.038497
Abstract
Stress activates the hypothalamic-pituitary-adrenal axis through release of corticotropin releasing hormone (CRH), leading to production of glucocorticoids that down-regulate immune responses. Acute stress, however, also has proinflammatory effects that seem to be mediated through the activation of mast cells. Stress and mast cells have been implicated in the pathophysiology of various inflammatory conditions, including some in the central nervous system, such as multiple sclerosis in which disruption of the blood-brain barrier (BBB) precedes clinical symptoms. We previously showed that acute restraint stress increases rat BBB permeability to intravenous 99Tc gluceptate and that administration of the “mast cell stabilizer” disodium cromoglycate (cromolyn) inhibits this effect. In this study, we show that the CRH-receptor antagonist Antalarmin blocks stress-induced 99Tc extravasation, whereas site-specific injection of CRH in the paraventricular nucleus (PVN) of the hypothalamus mimics acute stress. This latter effect is blocked by pretreatment of the PVN with cromolyn; moreover, restraint stress cannot disrupt the BBB in the diencephalon and cerebellum of W/Wv mast cell-deficient mice. These results demonstrate that CRH and mast cells are involved in regulating BBB permeability and, possibly, brain inflammatory disorders exacerbated by acute stress.Keywords
This publication has 55 references indexed in Scilit:
- Effects of sodium cromoglycate on cytokine production following antigen stimulation of a passively sensitized human lung modelAnnals of Allergy, Asthma & Immunology, 2000
- TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overviewJournal of Neuroimmunology, 1997
- In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammationEndocrinology, 1996
- Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factorNature, 1995
- Inhibition of tumour necrosis factor-alpha (TNF-α) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodiumClinical and Experimental Immunology, 1995
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Autocrine or Paracrine Inflammatory Actions of Corticotropin-Releasing Hormone in VivoScience, 1991
- The intracerebroventricularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in ratsInflammation Research, 1991
- Mast cells: The immune gate to the brainLife Sciences, 1990
- Comparison of human lung and intestinal mast cellsJournal of Allergy and Clinical Immunology, 1988